H. Nakano

发表

Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases

M. Tsuneyoshi, K. Ariyoshi, S. Kawauchi, 2000, Histopathology.

Expression of α-Smooth Muscle Actin in Benign or Malignant Ovarian Tumors

T. Kaku, H. Nakano, Toshiaki Saito, 1993 .

Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer.

T. Kaku, H. Nakano, T. Hirakawa, 1997, Gynecologic oncology.

Clinico‐cytological study of uterine papillary serous carcinoma

T. Kaku, H. Nakano, T. Hirakawa, 2005, Cytopathology : official journal of the British Society for Clinical Cytology.

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.

H. Tsuda, H. Yoshikawa, T. Kaku, 2001, Cancer letters.

Predicting pelvic lymph node metastasis in endometrial carcinoma.

T. Kaku, H. Nakano, H. Nakano, 1999, Gynecologic oncology.

Association of endometrial epithelial metaplasias with endometrial carcinoma and hyperplasia in Japanese and American women.

T. Kaku, H. Nakano, H. Nakano, 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

T. Kaku, H. Nakano, T. Hirakawa, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Early adenocarcinoma of the uterine cervix.

T. Kaku, H. Nakano, T. Saito, 1997, Gynecologic oncology.

The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining.

M. Tsuneyoshi, T. Kaku, H. Nakano, 1995, Gynecologic oncology.

Adenoma malignum of the uterine cervix detected by imaging methods in a patient with Peutz-Jeghers syndrome.

T. Kaku, H. Nakano, T. Kamura, 1994, Gynecologic oncology.

The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.

T. Kaku, H. Nakano, T. Hirakawa, 2000, Gynecologic oncology.

Cytological study of early cervical adenocarcinoma: special reference to the depth of invasion

T. Kaku, H. Nakano, T. Hirakawa, 2005, Cytopathology : official journal of the British Society for Clinical Cytology.

Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles.

T. Kaku, H. Nakano, T. Saito, 1998, Gynecologic oncology.

Ovarian mucinous cystadenocarcinoma with sarcoma-appearing mural nodule of anaplastic carcinoma.

T. Kaku, H. Nakano, T. Saito, 1993, Gynecologic oncology.

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.

K. Ariyoshi, T. Kaku, H. Nakano, 2000, Gynecologic oncology.

Urinary Incontinence in Women Seen in the Obstetrics and Gynecology Clinic

H. Nakano, T. Hirakawa, M. Luna, 2000, International Urogynecology Journal.

Endometrial carcinoma associated with hyperplasia.

T. Kaku, H. Nakano, T. Hirakawa, 1996, Gynecologic oncology.

Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature.

M. Tsuneyoshi, S. Kawauchi, T. Kaku, 1998, The American journal of surgical pathology.

Establishment of a new human uterine cervical adenocarcinoma cell-line, siso, and its reactivity to anticancer reagents.

H. Nakano, H. Nakano, M. Nakashima, 1995, International journal of oncology.

Endometrial carcinoma associated with hyperplasia--immunohistochemical study of angiogenesis and p53 expression.

T. Kaku, H. Nakano, T. Hirakawa, 1999, Gynecologic oncology.

Identification of chemotherapeutic refractory cases based on human chorionic gonadotropin values among patients with low-risk persistent trophoblastic disease treated with 8-day methotrexate-folinic acid.

N. Kinukawa, H. Nakano, T. Hirakawa, 2003, European journal of gynaecological oncology.

Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection — an analysis with mathematical statistics

N. Tsukamoto, T. Kaku, H. Nakano, 1992, International Journal of Gynecologic Cancer.

Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix.

N. Kinukawa, K. Ariyoshi, T. Kaku, 1999, Gynecologic oncology.

Relationship between age, histological type, and size of ovarian tumors

T Hirakawa, H. Nakano, T. Hirakawa, 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Endometrial carcinoma in women aged 40 years or younger: a Japanese experience

T. Kaku, H. Nakano, T. Saito, 1992, International Journal of Gynecologic Cancer.

Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.

N. Kinukawa, K. Ariyoshi, T. Kaku, 1999, Gynecologic oncology.

Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern.

T. Kaku, H. Nakano, T. Saito, 1997, Gynecologic oncology.